FindTrial
Sign In

Metabonomics study of propofol anesthesia

Metabonomics study of propofol anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037911
Enrollment
Unknown
Registered
2020-09-04
Start date
2020-09-07
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Propofol anesthesia

Interventions

Group 1:No
Group 2:Intravenous propofol

Sponsors

Shenzhen People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-40 years; 2. Patients undergoing painless artificial abortion surgery on a selective basis; 3. Female patients; 4. Patients with informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with emergency operation; 2. Patients with ASA grade III or above; 3. Patients with a history of major diseases such as congenital heart disease, cardiomyopathy, rheumatic heart disease and pulmonary heart disease; 4. Patients who can't cooperate (mental disorder, consciousness disorder, intelligence disorder); 5. HIV positive patients; 6. The patients who received the second operation after admission; 7. Patients who refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Metabolomics analysis changes;—

Countries

China

Contacts

Public ContactDai Zhongliang

Shenzhen People's Hospital

daizhongliang@jnu.edu.cn+86 13530756996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026